Latest market price
23.23
+0.08+0.35%
OverviewShort InterestFilings
IBDInspire Corporate Bond ETF·AMEX
23.23+0.35%
TA
Loading chart...
Screen all →
VXUS-1.53%$82.37VUG-3.00%$85.06VTV-0.38%$228.02VO-0.95%$81.46VGT-4.32%$116.96VB-1.58%$290.05VWO-1.93%$55.51VIG-0.56%$247.76
Fund Snapshot
Category—Asset TypeFixed IncomeTagsbondsReturn% 1Y-1.11%Total Holdings12Perf Week0.00%
SponsorInspireETF TypeTags—Return% 3Y5.01%AUM$489.70MPerf Month0.96%
Fund FamilyBond TypeTags—Return% 5Y0.94%NAV/shPerf Quarter-1.65%
Index—Average MaturityTags—Return% 10Y52W High24.78 -6.26%Perf Half Y-2.64%
Index WeightingCommodity TypeTags—Return% SI52W Low22.50 3.24%Perf YTD-4.01%
Active/PassiveQuant TypeTags—Flows% 1M3.55%Volatility0.43% 1.56%Perf Year-3.69%
Dividend TTM1.03 (4.41%)ESG TypeTags—Flows% 3M3.46%ATR (14)0.29Perf 3Y3.71%
Dividend Ex-DateOct 28, 2026Dividend TypeSector/ThemeFlows% YTD5.74%RSI (14)51.99Perf 5Y-10.34%
Dividend Gr. 3/5Y—Structure TypeRegionFlows% 1YBeta0.20Perf 10Y—
Expense0.41%Growth/ValueSMA200.34%Flows% 3YRel Volume1.08Prev Close23.15
Inverse/LeveragedMarket CapSMA50-0.20%Flows% 5YAvg Volume102.26KPrice23.23
IPO DateJul 10, 2017Option/ShortYes / YesSMA200-2.12%52W Range %32%Volume110,505Change0.35%
Assets Under Management
0150.00M300.00M450.00M600.00MAprJunAugOct'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Oct-26-26
Oct-26-2602:05PM
Bonds, AI, And A Bull Market That Has Kept GoingSeekingAlpha
Oct-21-26
Oct-21-2603:18PM
How Did This Low-Growth Stock Sneak Into IBD Growth Screens?investors.com
Oct-20-26
Oct-20-2603:17PM
Meta's $1,000 Bull Case: How Muse AI Changes The Valuation Game | IBDyoutube.com
Oct-19-26
Oct-19-2611:35AM
Are We There Yet? Bull Market May Have More MilesSeekingAlpha
Oct-17-26
Oct-17-2602:00AM
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026prnewswire.com
Oct-14-26
Oct-14-2607:21AM
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?zacks.com
Oct-11-26
Oct-11-2602:00PM
Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026gurufocus.com
02:00PM
New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Diseasegurufocus.com
Oct-10-26
Oct-10-2604:00AM
New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026gurufocus.com
Oct-07-26
Oct-07-2602:18PM
Spyre: Maintain 'Strong Buy' On Additional SPY072 Shots On Goal Q4 2026 And IBD Combination Potentialseekingalpha.com
05:25AM
Navigate 'Higher For Longer' With Floating Rate Bond ETFsSeekingAlpha
Oct-01-26
Oct-01-2606:00AM
Fixed-Income Outlook: 4 Ways To Capitalize On DispersionSeekingAlpha
Sep-25-26
Sep-25-2604:11AM
Credit Markets Confront An Unprecedented AI Financing CycleSeekingAlpha
Sep-21-26
Sep-21-2601:49PM
AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why.investors.com
Sep-09-26
Sep-09-2610:45PM
Columbia Threadneedle Fixed-Income Monitor: September 2026SeekingAlpha
Fund

The Inspire Corporate Bond ETF primarily invests in high-quality debt securities issued by large American corporations that are selected for their inspiring and biblically aligned principles. This fund aims to mirror the performance outcomes of the Inspire Corporate Bond Index.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR